Georg Fischer AG (SWX:GF)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 5.24B |
| Revenue (ttm) | 3.74B |
| Net Income (ttm) | 277.00M |
| Shares Out | 81.94M |
| EPS (ttm) | 3.38 |
| PE Ratio | 21.64 |
| Forward PE | 20.42 |
| Dividend | 1.35 (2.11%) |
| Ex-Dividend Date | Apr 22, 2025 |
| Volume | 248,254 |
| Average Volume | 165,084 |
| Open | 65.35 |
| Previous Close | 65.55 |
| Day's Range | 63.95 - 65.85 |
| 52-Week Range | 50.00 - 74.20 |
| Beta | 1.15 |
| RSI | 52.81 |
| Earnings Date | Jul 18, 2025 |
About Theseus Pharmaceuticals
Georg Fischer AG engages in the provision of piping systems, and casting and machining solutions in Europe, the Americas, Asia, and internationally. The company operates through three divisions: GF Piping Systems, GF Building Flow Solutions, and GF Casting Solutions. The GF Piping Systems segment provides system solutions, and plastic and metal components, including fittings, valves, pipes, automation, and jointing technologies for various water cycle applications. The division also offers specialized solutions, including engineering, customizi... [Read more]
Financial Performance
In 2024, Georg Fischer AG's revenue was 3.89 billion, an increase of 23.99% compared to the previous year's 3.14 billion. Earnings were 214.00 million, a decrease of -8.94%.
Financial StatementsNews
Georg Fischer - Decent Returns Since Last Time, Good Swiss Water Company With A 'Buy'
Georg Fischer AG is a Swiss leader in water solutions, focusing on sustainable growth. Click here to read an analysis on FCHRF stock now.
Georg Fischer - Following Up The Buyer Of Uponor
Georg Fischer AG acquired Uponor, becoming the world leader in Water & Flow solutions. Georg Fischer operates in multiple fields, with over 60% of revenues from water, making it a significant player i...